Good gene, bad gene: new APP variant may be both

Area of Science:

• Genetics
• Neuroscience
• Biochemistry

Background:

• Amyloid precursor protein (APP) mutations are a known cause of Alzheimer disease (AD).
• The A673V mutation in APP was identified in a family with early-onset dementia.
• This mutation appears to be inherited in an autosomal recessive pattern.

Purpose of the Study:

• To investigate the pathogenic mechanisms of the novel APP A673V mutation.
• To explore the potential of Aβ peptides as a therapeutic strategy for AD.

Main Methods:

• Genetic analysis of affected family members.
• Biochemical assays to study APP processing and Aβ aggregation.
• In vitro studies using mutated and wild-type Aβ peptides.

Main Results:

• The homozygous A673V mutation increases Aβ production and enhances Aβ aggregation.
• Heterozygous carriers of the mutation do not develop AD, and mutated Aβ inhibits wild-type Aβ aggregation.
• A D-amino acid-based peptide derived from the mutated Aβ sequence demonstrated enhanced stability and anti-amyloidogenic properties.

Conclusions:

• The A673V mutation provides a new model for autosomal recessive AD pathogenesis.
• The anti-amyloidogenic properties of this Aβ variant offer a promising basis for developing novel AD therapies.